Yoshino I, Goedegebuure P S, Peoples G E, Lee K Y, Eberlein T J
Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115.
J Immunol. 1994 Nov 1;153(9):4149-58.
Human tumor-infiltrating lymphocytes (TIL) include a minor population of tumor-specific T cells, but the nature of the majority of TIL remains unknown. Recently, it has been suggested that T cells that recognize stressed cells may play an important role in immune surveillance. We have examined the proliferative response of anti-CD3-activated TIL cultures from human tumors against heat-stressed (hs) (42.8 degrees C, 25 min) B cell lines (TK6 (HLA-DR7+, -DRw13+, -DRw52+, and -DRw53+) and JY (HLA-DR4+ and -DRw52+)) and the mutant cell line (T2 (no HLA-DR)) by measuring [3H]thymidine incorporation. TIL lines from three of four ovarian cancers, two of four lung cancers, one of two renal cell cancers, one of two melanomas, and one of one breast cancer showed a positive proliferative response against hs-TK6 and/or hs-JY, but not against hs-T2. These TIL did not respond to autologous tumor cells. The response to hs-B cells was mediated by CD4+ TIL and inhibited by anti-HLA-DR Ab, but not by anti-HLA class I. Protein analysis revealed a significant increase of heat shock protein 70 (hsp70) expression in hs-TK6 and hs-JY. In addition, the CD4+ TIL responded to TK6 that had been pulsed with hsp70. This response could be blocked by anti-HLA-DR Ab. The CD4+ TIL produced IFN-gamma, but not IL-4, in response to hs-TK6. From these results, we conclude that hsp70-reactive CD4+ T cells exist in tumor tissues. Furthermore, these TIL recognize stressed cells and seem to play a Th1-like role that may support antitumor T cell responses at local tumor sites.
人类肿瘤浸润淋巴细胞(TIL)包含一小部分肿瘤特异性T细胞,但大多数TIL的性质仍不清楚。最近,有人提出识别应激细胞的T细胞可能在免疫监视中起重要作用。我们通过测量[3H]胸苷掺入量,检测了来自人类肿瘤的抗CD3激活的TIL培养物对热应激(hs)(42.8摄氏度,25分钟)B细胞系(TK6(HLA-DR7 +、-DRw13 +、-DRw52 +和-DRw53 +)和JY(HLA-DR4 +和-DRw52 +))以及突变细胞系(T2(无HLA-DR))的增殖反应。来自四例卵巢癌中的三例、四例肺癌中的两例、两例肾细胞癌中的一例、两例黑色素瘤中的一例以及一例乳腺癌的TIL系对hs-TK6和/或hs-JY显示出阳性增殖反应,但对hs-T2无反应。这些TIL对自体肿瘤细胞无反应。对hs-B细胞的反应由CD4 + TIL介导,并被抗HLA-DR抗体抑制,但不受抗HLA I类抗体抑制。蛋白质分析显示hs-TK6和hs-JY中热休克蛋白70(hsp70)表达显著增加。此外,CD4 + TIL对用hsp70脉冲的TK6有反应。这种反应可被抗HLA-DR抗体阻断。CD4 + TIL对hs-TK6产生IFN-γ,但不产生IL-4。从这些结果中,我们得出结论,肿瘤组织中存在hsp70反应性CD4 + T细胞。此外,这些TIL识别应激细胞,似乎发挥类似Th1的作用,可能支持局部肿瘤部位的抗肿瘤T细胞反应。